Protara Therapeutics, Inc.

2.56 USD
-0.01 (-0.39%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Protara Therapeutics, Inc. stock is down -31.55% since 30 days ago. The next earnings date is Aug 1, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 9 June’s closed higher than May.

About Protara Therapeutics, Inc.

Protara Therapeutics, Inc. engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the. treatment of lymphatic malformations. It also develops intravenous choline chloride, an. investigational phospholipid substrate replacement therapy.